Beryl Capital Management LLC 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 1:14 pm Sale | 2024-09-30 | 13G | G1 Therapeutics, Inc. GTHX | Beryl Capital Management LLC | 0 0.000% | -5,179,529 (Position Closed) | Filing |
| 2024-08-19 7:02 pm Purchase | 2024-08-07 | 13G | G1 Therapeutics, Inc. GTHX | Beryl Capital Management LLC | 5,179,529 9.800% | 5,179,529 (New Position) | Filing |